The Financial Regulatory Authority (FRA) is set to update its regulatory framework for approving insurance products, and to conduct a comprehensive review the terms and models of insurance policies for all branches of business.
China's insurance industry entered a new regulatory phase on 1 July as three significant policy measures took effect, introducing stricter product suitability rules, greater transparency in bancassurance fees and lower projected returns for participating insurance products.
Indonesia's general insurance industry is expected to remain under pressure in 2026 despite sustained demand for insurance protection, as rising claims and volatile investment returns continue to weigh on insurers' financial performance.
The Insurance Regulatory Commission of Sri Lanka's (IRCSL) focus on its "Insurance Vision 2035" plan is a significant step in building a reliable and resilient insurance industry in the country.
New Zealand's Financial Markets Authority (FMA) has released its second annual Financial Conduct Report (FCR), outlining progress made over the past year and its regulatory priorities for FY2026/27 to continue improving outcomes for consumers, investors and businesses.
A new proposal by the Pharmacy Board of Australia's (PBA) consultation on endorsement for scheduled medicines for pharmacists may lead to higher risks to public health, due to a lack of extensive training, supervision and experience doctors usually have to diagnose a patient and prescribe the appropriate medication.
The General Insurance Association of Japan (GIAJ) appointed Mr Ishikawa Koji as Chairman at its Annual General Meeting on 30 June 2026.
The National Insurance Commission (NAICOM) has announced that it had granted a Partnering InsurTech licence to NETAPPS, a start-up, reinforcing the insurance regulator's commitment to leveraging digital innovation to deepen insurance penetration and expand access across Nigeria.
The Australian Prudential Regulation Authority (APRA) has published the findings of its inaugural System Risk Stress Test, which focused on links between the banking and superannuation systems.
The National Healthcare Security Administration (NHSA) has conducted its preliminary review of 557 drugs for inclusion in the national basic medical insurance drug list, while another 54 have been provisionally approved for the commercial health insurance drug catalogue, reported the China Daily.